1. Home
  2. TPVG vs NERV Comparison

TPVG vs NERV Comparison

Compare TPVG & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriplePoint Venture Growth BDC Corp.

TPVG

TriplePoint Venture Growth BDC Corp.

HOLD

Current Price

$4.48

Market Cap

224.9M

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.11

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPVG
NERV
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.9M
210.1M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
TPVG
NERV
Price
$4.48
$4.11
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$5.90
$10.50
AVG Volume (30 Days)
257.3K
358.2K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
17.66%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
$7.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.41
$1.76
52 Week High
$7.24
$12.46

Technical Indicators

Market Signals
Indicator
TPVG
NERV
Relative Strength Index (RSI) 37.96 40.62
Support Level N/A $3.80
Resistance Level $5.70 $4.59
Average True Range (ATR) 0.16 0.38
MACD -0.00 -0.01
Stochastic Oscillator 15.32 18.81

Price Performance

Historical Comparison
TPVG
NERV

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: